Potential Efficacy of Broccoli Sprouts as a Unique Supplement for Management of Type 2 Diabetes and Its Complications
Publication: Journal of Medicinal Food
Volume 16, Issue Number 5
Abstract
Functional foods and their nutraceutical components are now considered as supplementary treatments in type 2 diabetes and prevention of its long-term complications. Young broccoli sprouts as a functional food contain many bioactive compounds specially sulforaphane. In hyperglycemic and oxidative conditions, sulforaphane has the potential to activate the NF-E2–related factor-2 (Nrf2)–dependent antioxidant response-signaling pathway, induces phase 2 enzymes, attenuates oxidative stress, and inactivates nuclear factor kappa-B (NF-κB), a key modulator of inflammatory pathways. Interestingly, sulforaphane induces some peroxisome proliferator-activated receptors, which contribute to lipid metabolism and glucose homeostasis. In animal and in vitro models, sulforaphane also shows antihypertensive, anticancer, cardioprotective, and hypocholesterolemic capacity, and has bactericidal properties against Helicobacter pylori. Supplementation of type 2 diabetics with high sulforaphane content broccoli sprouts resulted in increased total antioxidant capacity of plasma and in decreased oxidative stress index, lipid peroxidation, serum triglycerides, oxidized low-density lipoprotein (LDL)/LDL-cholesterol ratio, serum insulin, insulin resistance, and serum high-sensitive C-reactive protein. Sulforaphane could prevent nephropathy, diabetes-induced fibrosis, and vascular complications. Potential efficacy of sulforaphane and probably other bioactive components of young broccoli sprouts makes it as an excellent choice for supplementary treatment in type 2 diabetes.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Evans JLGoldfine IDMaddux BAGrodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetesEndocr Rev200223599-622. 1. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002;23:599–622.
2.
Goycheva VGadjeva B. Popov: oxidative stress and its complications in diabetes mellitusTrakia J Sci200641-8. 2. Goycheva V, Gadjeva B: Popov: oxidative stress and its complications in diabetes mellitus. Trakia J Sci 2006;4:1–8.
3.
Santaguida PLBalion CHunt D. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucoseEvid Rep Technol Assess2008121-11. 3. Santaguida PL, Balion C, Hunt D: Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evid Rep Technol Assess 2008;12:1–11.
4.
Dämon SSchätzer MHöfler JTomasec GHoppichler F. Nutrition and diabetes mellitus: an overview of the current evidenceWien Med Wochenschr2011161282-288. 4. Dämon S, Schätzer M, Höfler J, Tomasec G, Hoppichler F: Nutrition and diabetes mellitus: an overview of the current evidence. Wien Med Wochenschr 2011;161:282–288.
5.
Carvajal MBerenguer CViguera C. Chemical and biological characterisation of nutraceutical compounds of broccoliJ Pharma Biomed Anal2006411508-1522. 5. Carvajal M, Berenguer C, Viguera C: Chemical and biological characterisation of nutraceutical compounds of broccoli. J Pharma Biomed Anal 2006;41:1508–1522.
6.
Jeffery EAraya M. Physiological effects of broccoli consumptionPhytochem Rev20098283-298. 6. Jeffery E, Araya M: Physiological effects of broccoli consumption. Phytochem Rev 2009;8:283–298.
7.
Wu LNoyan Ashraf MHFacci M et al. Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular systemProc Natl Acad Sci USA20041017094-7099. 7. Wu L, Noyan Ashraf MH, Facci M, et al.: Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. Proc Natl Acad Sci USA 2004;101:7094–7099.
8.
Lee JShin HLee YKim ALee M. Effect of Broccoli sprouts on cholesterol-lowering and anti-obesity effects in rats fed high fat dietJ Korean Soc Food Sci Nutr200938309-318. 8. Lee J, Shin H, Lee Y, Kim A, Lee M: Effect of Broccoli sprouts on cholesterol-lowering and anti-obesity effects in rats fed high fat diet. J Korean Soc Food Sci Nutr 2009;38:309–318.
9.
Keum YJeong WKong T. Chemoprevention by isothiocyanates and underlying molecular signaling mechanismsMutat Res2004555191-202. 9. Keum Y, Jeong W, Kong T: Chemoprevention by isothiocyanates and underlying molecular signaling mechanisms. Mutat Res 2004;555:191–202.
10.
Verkerk RSchreiner MKrumbein A. Glucosinolates in brassica vegetable: the influence of the food supply chain on intake, bioavailability and human healthMol Nutr Food Res200953S219-S266. 10. Verkerk R, Schreiner M, Krumbein A: Glucosinolates in brassica vegetable: the influence of the food supply chain on intake, bioavailability and human health. Mol Nutr Food Res 2009;53:S219–S266.
11.
Xue MQian QAdaikalakoteswari ARabbani NBabaei-Jadidi RThornalley PJ. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular diseaseDiabetes2008572809-2817. 11. Xue M, Qian Q, Adaikalakoteswari A, Rabbani N, Babaei-Jadidi R, Thornalley PJ: Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 2008;57:2809–2817.
12.
Zhu HJia ZStrobl JSEhrich MMisra HPLi Y. Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stressCardiovasc Toxicol20088115-125. 12. Zhu H, Jia Z, Strobl JS, Ehrich M, Misra HP, Li Y: Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress. Cardiovasc Toxicol 2008;8:115–125.
13.
Piao XLKim HYYokozawa TLee YAPiao XSCho EJ. Protective effects of broccoli (Brassica oleracea) and its active components against radical-induced oxidative damageJ Nutr Sci Vitaminol200551142-147. 13. Piao XL, Kim HY, Yokozawa T, Lee YA, Piao XS, Cho EJ: Protective effects of broccoli (Brassica oleracea) and its active components against radical-induced oxidative damage. J Nutr Sci Vitaminol 2005;51:142–147.
14.
Riedl MASaxon ADiaz-Sanchez D. Oral sulforaphane increases phase II antioxidant enzymes in the human upper airwayClin Immunol2009130244-251. 14. Riedl MA, Saxon A, Diaz-Sanchez D: Oral sulforaphane increases phase II antioxidant enzymes in the human upper airway. Clin Immunol 2009;130:244–251.
15.
Heiss EHerhaus CKlimo KBartsch HGerhäuser C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanismsJ Biol Chem200127632008-32015. 15. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhäuser C: Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 2001;276:32008–32015.
16.
Mukherjee SGangopadhyay HDas DK. Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamilyJ Agric Food Chem200856609-617. 16. Mukherjee S, Gangopadhyay H, Das DK: Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily. J Agric Food Chem 2008;56:609–617.
17.
Fahey JWHaristoy XDolan PM et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumorsProc Natl Acad Sci USA2002997610-7615. 17. Fahey JW, Haristoy X, Dolan PM, et al.: Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci USA 2002;99:7610–7615.
18.
Han JMLee YJLee SY et al. Protective effect of sulforaphane against dopaminergic cell deathJ Pharmacol Exp Ther2007321249-256. 18. Han JM, Lee YJ, Lee SY, et al.: Protective effect of sulforaphane against dopaminergic cell death. J Pharmacol Exp Ther 2007;321:249–256.
19.
Myzak MCDashwood WMOrner GAHo EDashwood RH. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus miceFASEB J200620506-508. 19. Myzak MC, Dashwood WM, Orner GA, Ho E, Dashwood RH: Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J 2006;20:506–508.
20.
Hu RXu CShen G et al. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) miceCancer Lett2006243170-192. 20. Hu R, Xu C, Shen G, et al.: Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Lett 2006;243:170–192.
21.
Valko MLeibfritz DMoncol JCronin MTMazur MTelser J. Free radicals and antioxidants in normal physiological functions and human diseaseInt J Biochem Cell Biol20073944-84. 21. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44–84.
22.
Opara ECAbdel-Rahman ESoliman S. Depletion of total antioxidant capacity in type 2 diabetesMetabolism1999481414-1417. 22. Opara EC, Abdel-Rahman E, Soliman S: Depletion of total antioxidant capacity in type 2 diabetes. Metabolism 1999;48:1414–1417.
23.
Pérez-Matute PZulet MAMartínez JA. Reactive species and diabetes: counteracting oxidative stress to improve healthCurr Opin Pharmacol20099771-779. 23. Pérez-Matute P, Zulet MA, Martínez JA: Reactive species and diabetes: counteracting oxidative stress to improve health. Curr Opin Pharmacol 2009;9:771–779.
24.
Maritim ACSanders RAWatkins JB. Diabetes, oxidative stress, and antioxidants: a reviewJ Biochem Mol Toxicol20031724-38. 24. Maritim AC, Sanders RA, Watkins JB: Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24–38.
25.
Boddupalli SMein JRLakkanna SJames DR. Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins A, C, and EFront Genet201237. 25. Boddupalli S, Mein JR, Lakkanna S, James DR: Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins A, C, and E. Front Genet 2012;3:7.
26.
Evcimen NDKing GL. The role of protein kinase C activation and the vascular complications of diabetesPharmacol Res200755498-510. 26. Evcimen ND, King GL: The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 2007;55:498–510.
27.
Wright E JrScism-Bacon JLGlass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemiaInt J Clin Pract200660308-314. 27. Wright E Jr, Scism-Bacon JL, Glass LC: Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 2006;60:308–314.
28.
Cho EJLee YAYoo HHYokozawa T. Protective effects of broccoli (Brassica oleracea) against oxidative damage in vitro and in vivoJ Nutr Sci Vitaminol (Tokyo)200652437-444. 28. Cho EJ, Lee YA, Yoo HH, Yokozawa T: Protective effects of broccoli (Brassica oleracea) against oxidative damage in vitro and in vivo. J Nutr Sci Vitaminol (Tokyo) 2006;52:437–444.
29.
Bahadoran ZMirmiran PHosseinpanah FHedayati MHosseinpour-Niazi SAzizi F. Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trialEur J Clin Nutr201165972-977. 29. Bahadoran Z, Mirmiran P, Hosseinpanah F, Hedayati M, Hosseinpour-Niazi S, Azizi F: Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial. Eur J Clin Nutr 2011;65:972–977.
30.
Murashima MWatanabe SZhuo XGUehara MKurashige A. Phase 1 study of multiple biomarkers for metabolism and oxidative stress after one-week intake of broccoli sproutsBiofactors200422271-275. 30. Murashima M, Watanabe S, Zhuo XG, Uehara M, Kurashige A: Phase 1 study of multiple biomarkers for metabolism and oxidative stress after one-week intake of broccoli sprouts. Biofactors 2004;22:271–275.
31.
Kaspar JWNiture SKJaiswal AK. Nrf2: INrf2 (Keap1) signaling in oxidative stressFree Radic Biol Med2009471304-1309. 31. Kaspar JW, Niture SK, Jaiswal AK: Nrf2: INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 2009;47:1304–1309.
32.
Hybertson BMGao BBose SKMcCord JM. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activationMol Aspects Med201132234-246. 32. Hybertson BM, Gao B, Bose SK, McCord JM: Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med 2011;32:234–246.
33.
Spranger JKroke AMöhlig M et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam StudyDiabetes200352812-817. 33. Spranger J, Kroke A, Möhlig M, et al.: Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003;52:812–817.
34.
King GL. The role of inflammatory cytokines in diabetes and its complicationsJ Periodontol2008791527-1534. 34. King GL: The role of inflammatory cytokines in diabetes and its complications. J Periodontol 2008;79:1527–1534.
35.
Sjöholm ANyström T. Inflammation and the etiology of type 2 diabetesDiabetes Metab Res Rev2006224-10. 35. Sjöholm A, Nyström T: Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev 2006;22:4–10.
36.
Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complicationsJ Clin Endocrinol Metab2009943171-3182. 36. Goldberg RB: Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009;94:3171–3182.
37.
Abdin AABaalash AAHamooda HE. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markersJ Diabetes Complications201024168-178. 37. Abdin AA, Baalash AA, Hamooda HE: Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers. J Diabetes Complications 2010;24:168–178.
38.
Ritz SAWan JDiaz-Sanchez D. Sulforaphane-stimulated phase II enzyme induction inhibits cytokine production by airway epithelial cells stimulated with diesel extractAm J Physiol Lung Cell Mol Physiol2007292L33-L39. 38. Ritz SA, Wan J, Diaz-Sanchez D: Sulforaphane-stimulated phase II enzyme induction inhibits cytokine production by airway epithelial cells stimulated with diesel extract. Am J Physiol Lung Cell Mol Physiol 2007;292:L33–L39.
39.
Shan YZhao RGeng W et al. Protective effect of sulforaphane on human vascular endothelial cells against lipopolysaccharide-induced inflammatory damageCardiovasc Toxicol201010139-145. 39. Shan Y, Zhao R, Geng W, et al.: Protective effect of sulforaphane on human vascular endothelial cells against lipopolysaccharide-induced inflammatory damage. Cardiovasc Toxicol 2010;10:139–145.
40.
Lin WWu RTWu TKhor TOWang HKong AN. Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathwayBiochem Pharmacol200876967-973. 40. Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN: Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem Pharmacol 2008;76:967–973.
41.
Mirmiran PBahadoran ZHosseinpanah ZKeyzad AAzizi F. Effects of broccoli sprouts with high sulforaphane concentration on inflammatory markers in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trialJ Funct Foods20124837-841. 41. Mirmiran P, Bahadoran Z, Hosseinpanah Z, Keyzad A, Azizi F: Effects of broccoli sprouts with high sulforaphane concentration on inflammatory markers in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. J Funct Foods 2012;4:837–841.
42.
Aggarwal BBTakada YShishodia SGutierrez AMOommen OVIchikawa H et al. Nuclear transcription factor NF-kappa B: role in biology and medicineIndian J Exp Biol200442341-353. 42. Aggarwal BB, Takada Y, Shishodia S, Gutierrez AM, Oommen OV, Ichikawa H, et al.: Nuclear transcription factor NF-kappa B: role in biology and medicine. Indian J Exp Biol 2004;42:341–353.
43.
Lebovitz HE. Insulin resistance: definition and consequencesExp Clin Endocrinol Diabetes2001109S135-S148. 43. Lebovitz HE: Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 2001;109:S135–S148.
44.
Henriksen EJDiamond-Stanic MKMarchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetesFree Radic Biol Med200151993-999. 44. Henriksen EJ, Diamond-Stanic MK, Marchionne EM: Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 2001;51:993–999.
45.
Hoehn KLSalmon ABHohnen-Behrens C et al. Insulin resistance is a cellular antioxidant defense mechanismProc Natl Acad Sci USA200910617787-17792. 45. Hoehn KL, Salmon AB, Hohnen-Behrens C, et al.: Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci USA 2009;106:17787–17792.
46.
Park KGross MLee DH et al. Oxidative stress and insulin resistance: the coronary artery risk development in young adults studyDiabetes Care2009321302-1307. 46. Park K, Gross M, Lee DH, et al.: Oxidative stress and insulin resistance: the coronary artery risk development in young adults study. Diabetes Care 2009;32:1302–1307.
47.
Evans JL. Antioxidants: do they have a role in the treatment of insulin resistance?Indian J Med Res2007125355-372. 47. Evans JL: Antioxidants: do they have a role in the treatment of insulin resistance? Indian J Med Res 2007;125:355–372.
48.
Bahadoran ZTohidi MNazeri PMehran MAzizi FMirmiran P. Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: a randomized double-blind clinical trialInt J Food Sci Nutr201263767-761. 48. Bahadoran Z, Tohidi M, Nazeri P, Mehran M, Azizi F, Mirmiran P: Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: a randomized double-blind clinical trial. Int J Food Sci Nutr 2012;63:767–761.
49.
Patel SSantani D. Role of NF-kappa B in the pathogenesis of diabetes and its associated complicationsPharmacol Rep200961595-603. 49. Patel S, Santani D: Role of NF-kappa B in the pathogenesis of diabetes and its associated complications. Pharmacol Rep 2009;61:595–603.
50.
Haluzík MMHaluzík M. PPAR-alpha and insulin sensitivityPhysiol Res200655115-122. 50. Haluzík MM, Haluzík M: PPAR-alpha and insulin sensitivity. Physiol Res 2006;55:115–122.
51.
Nicolucci ADe Berardis GSacco MTognoni G. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes AssociationDiabetes Care200730162-172. 51. Nicolucci A, De Berardis G, Sacco M, Tognoni G: Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007;30:162–172.
52.
Bahadoran ZMirmiran PHosseinpanah FRajab AAsghari GAzizi F. Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trialDiabetes Res Clin Pract201296348-354. 52. Bahadoran Z, Mirmiran P, Hosseinpanah F, Rajab A, Asghari G, Azizi F: Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Diabetes Res Clin Pract 2012;96:348–354.
53.
Christiansen BBellostas Muguerza NPetersen AM et al. Ingestion of broccoli sprouts does not improve endothelial function in humans with hypertensionPLoS One20105e12461. 53. Christiansen B, Bellostas Muguerza N, Petersen AM, et al.: Ingestion of broccoli sprouts does not improve endothelial function in humans with hypertension. PLoS One 2010;5:e12461.
54.
Kahlon TSChapman MHSmith GE. In vitro binding of bile acids by spinach, kale, brusseles sprouts, broccoli, mustard green, green bell pepper, cabbage and collardsFood Chem20071001531-1536. 54. Kahlon TS, Chapman MH, Smith GE: In vitro binding of bile acids by spinach, kale, brusseles sprouts, broccoli, mustard green, green bell pepper, cabbage and collards. Food Chem 2007;100:1531–1536.
55.
Dunn SELeBlanc GA. Hypocholesterolemic properties of plant indoles. Inhibition of acyl-CoA:cholesterol acyltransferase activity and reduction of serum LDL/VLDL cholesterol levels by glucobrassicin derivativesBiochem Pharmacol199447359-364. 55. Dunn SE, LeBlanc GA: Hypocholesterolemic properties of plant indoles. Inhibition of acyl-CoA:cholesterol acyltransferase activity and reduction of serum LDL/VLDL cholesterol levels by glucobrassicin derivatives. Biochem Pharmacol 1994;47:359–364.
56.
Maiyoh GKKuh JECasaschi ATheriault AG. Cruciferous indole-3-carbinol inhibits apolipoprotein B secretion in HepG2 cellsJ Nutr20071372185-2189. 56. Maiyoh GK, Kuh JE, Casaschi A, Theriault AG: Cruciferous indole-3-carbinol inhibits apolipoprotein B secretion in HepG2 cells. J Nutr 2007;137:2185–2189.
57.
Huang JTabbi-Anneni IGunda VWang L. Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolismAm J Physiol Gastrointest Liver Physiol2010299G1211-1221. 57. Huang J, Tabbi-Anneni I, Gunda V, Wang L: Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. Am J Physiol Gastrointest Liver Physiol 2010;299:G1211–1221.
58.
Tavares VHirata MHHirata RD. Peroxisome proliferator-activated receptor gamma (PPARgamma): molecular study in glucose homeostasis, lipid metabolism and therapeuticArq Bras Endocrinol Metabol200751526-533. 58. Tavares V, Hirata MH, Hirata RD: Peroxisome proliferator-activated receptor gamma (PPARgamma): molecular study in glucose homeostasis, lipid metabolism and therapeutic. Arq Bras Endocrinol Metabol 2007;51:526–533.
59.
Marrollo MLatella GMelideo D et al. Increased prevalence of Helicobacter pylori in patients with diabetes mellitusDig Liver Dis20013321-29. 59. Marrollo M, Latella G, Melideo D, et al.: Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig Liver Dis 2001;33:21–29.
60.
Demir MGokturk HSOzturk NAKulaksizoglu MSerin EYilmaz U. Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complicationsDig Dis Sci2008532646-2649. 60. Demir M, Gokturk HS, Ozturk NA, Kulaksizoglu M, Serin E, Yilmaz U: Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci 2008;53:2646–2649.
61.
Hamed SAAmine NFGalal GM et al. Vascular risks and complications in diabetes mellitus. the role of helicobacter pylori infectionJ Stroke Cerebrovasc Dis20081786-94. 61. Hamed SA, Amine NF, Galal GM, et al.: Vascular risks and complications in diabetes mellitus. the role of helicobacter pylori infection. J Stroke Cerebrovasc Dis 2008;17:86–94.
62.
Tanriverd O. Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patientsTurk J Gastroenterol201122569-574. 62. Tanriverd O: Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients. Turk J Gastroenterol 2011;22:569–574.
63.
Wang SZShi YNZhao JWang ZD. Effects of Helicobacter pylori on blood glucose fluctuation in type 2 diabetic patientsZhonghua Yi Xue Za Zhi200989958-961. 63. Wang SZ, Shi YN, Zhao J, Wang ZD: Effects of Helicobacter pylori on blood glucose fluctuation in type 2 diabetic patients. Zhonghua Yi Xue Za Zhi 2009;89:958–961.
64.
Galan MVKishan AASilverman AL. Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary reportDis Dig Sci2004491088-1090. 64. Galan MV, Kishan AA, Silverman AL: Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report. Dis Dig Sci 2004;49:1088–1090.
65.
Yanaka AFahey JWFukumoto A et al. Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humansCancer Prev Res (Phila)20092353-360. 65. Yanaka A, Fahey JW, Fukumoto A, et al.: Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans. Cancer Prev Res (Phila) 2009;2:353–360.
66.
Putnam WBuhariwalla FLacey K et al. Drug management for hypertension in type 2 diabetes in family practiceCan Fam Physician200955728-734. 66. Putnam W, Buhariwalla F, Lacey K, et al.: Drug management for hypertension in type 2 diabetes in family practice. Can Fam Physician 2009;55:728–734.
67.
Jesmin JRashid MSJamil HHontecillas RBassaganya-Riera J. Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertensionBMC Med Genomics2010345. 67. Jesmin J, Rashid MS, Jamil H, Hontecillas R, Bassaganya-Riera J: Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertension. BMC Med Genomics 2010;3:45.
68.
Johnson JACarstensen BWitte DBowker SLLipscombe LRenehan AG. Diabetes and Cancer Research Consortium: Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidenceDiabetologia2012551607-1618. 68. Johnson JA, Carstensen B, Witte D, Bowker SL, Lipscombe L, Renehan AG; Diabetes and Cancer Research Consortium: Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence. Diabetologia 2012;55:1607–1618.
69.
Cannata DFierz YVijayakumar ALeRoith D. Type 2 diabetes and cancer: what is the connection?Mt Sinai J Med201077197-213. 69. Cannata D, Fierz Y, Vijayakumar A, LeRoith D: Type 2 diabetes and cancer: what is the connection? Mt Sinai J Med 2010;77:197–213.
70.
Vigneri PFrasca FSciacca LPandini GVigneri R. Diabetes and cancerEndocr Relat Cancer2009161103-1123. 70. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R: Diabetes and cancer. Endocr Relat Cancer 2009;16:1103–1123.
71.
Shapiro TAFahey JWWade KLStephenson KKTalalay P. Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humansCancer Epidemiol Biomarkers Prev200110501-508. 71. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P: Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans. Cancer Epidemiol Biomarkers Prev 2001;10:501–508.
72.
James DDevaraj SBellur PLakkanna SVicini JBoddupalli S. Novel concepts of broccoli sulforaphanes and disease: induction of phase II antioxidant and detoxification enzymes by enhanced-glucoraphanin broccoliNutr Rev201270654-665. 72. James D, Devaraj S, Bellur P, Lakkanna S, Vicini J, Boddupalli S: Novel concepts of broccoli sulforaphanes and disease: induction of phase II antioxidant and detoxification enzymes by enhanced-glucoraphanin broccoli. Nutr Rev 2012;70:654–665.
73.
Gamet-Payrastre LLi PLumeau S et al. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cellsCancer Res2000601426-1433. 73. Gamet-Payrastre L, Li P, Lumeau S, et al.: Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 2000;60:1426–1433.
74.
Pledgie-Tracy ASobolewski MDDavidson NE. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell linesMol Cancer Ther200761013-1021. 74. Pledgie-Tracy A, Sobolewski MD, Davidson NE: Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 2007;6:1013–1021.
75.
Valk EJBruijn JABajema IM. Diabetic nephropathy in humans: pathologic diversityCurr Opin Nephrol Hypertens201120285-289. 75. Valk EJ, Bruijn JA, Bajema IM: Diabetic nephropathy in humans: pathologic diversity. Curr Opin Nephrol Hypertens 2011;20:285–289.
76.
Kashihara NHaruna YKondeti VKKanwar YS. Oxidative stress in diabetic nephropathyCurr Med Chem2010174256-4269. 76. Kashihara N, Haruna Y, Kondeti VK, Kanwar YS: Oxidative stress in diabetic nephropathy. Curr Med Chem 2010;17:4256–4269.
77.
Li BLiu SMiao LCai L. Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathyExp Diabetes Res20122012216512. 77. Li B, Liu S, Miao L, Cai L: Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy. Exp Diabetes Res 2012;2012:216512.
78.
Zheng HWhitman SAWu W et al. Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathyDiabetes2011603055-3066. 78. Zheng H, Whitman SA, Wu W, et al.: Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 2011;60:3055–3066.
79.
Cui WBai YMiao X et al. Prevention of diabetic nephropathy by sulforaphane: possible role of nrf2 upregulation and activationOxid Med Cell Longev20122012821936. 79. Cui W, Bai Y, Miao X, et al.: Prevention of diabetic nephropathy by sulforaphane: possible role of nrf2 upregulation and activation. Oxid Med Cell Longev 2012;2012:821936.
80.
Creager MALüscher TFCosentino FBeckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part ICirculation20031081527-1532. 80. Creager MA, Lüscher TF, Cosentino F, Beckman JA: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 2003;108:1527–1532.
81.
Endemann DHSchiffrin EL. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitusCurr Hypertens Rep2004685-89. 81. Endemann DH, Schiffrin EL: Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Curr Hypertens Rep 2004;6:85–89.
82.
Zakkar MVan der Heiden KLuong le AChaudhury HCuhlmann SHamdulay SS. Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory stateArterioscler Thromb Vasc Biol2009291851-1857. 82. Zakkar M, Van der Heiden K, Luong le A, Chaudhury H, Cuhlmann S, Hamdulay SS: Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler Thromb Vasc Biol 2009;29:1851–1857.
83.
Miao XBai YSun W et al. Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidantsNutr Metab (Lond)2012984. 83. Miao X, Bai Y, Sun W, et al.: Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants. Nutr Metab (Lond) 2012;9:84.
84.
Ha HKim KH. Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase CDiabetes Res Clin Pract199945147-151. 84. Ha H, Kim KH: Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Res Clin Pract 1999;45:147–151.
85.
Chiang DJPritchard MTNagy LE. Obesity, diabetes mellitus, and liver fibrosisAm J Physiol Gastrointest Liver Physiol2011300G697-G702. 85. Chiang DJ, Pritchard MT, Nagy LE: Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2011;300:G697–G702.
86.
Oh CJKim JYMin AK et al. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signalingFree Radic Biol Med201252671-682. 86. Oh CJ, Kim JY, Min AK, et al.: Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. Free Radic Biol Med 2012;52:671–682.
Information & Authors
Information
Published In
Copyright
Copyright 2013, Mary Ann Liebert, Inc. and Korean Society of Food Science and Nutrition.
History
Published online: 15 May 2013
Published in print: May 2013
Published ahead of print: 30 April 2013
Accepted: 30 January 2013
Received: 4 September 2012
Topics
Authors
Author Disclosure Statement
No competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.